Matt Larew
Stock Analyst at William Blair
(4.84)
# 417
Out of 5,090 analysts
231
Total ratings
63.8%
Success rate
28.5%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Reiterated: Hold | n/a | $17.38 | - | 3 | Oct 6, 2026 | |
| OPCH Option Care Health | Reiterated: Buy | n/a | $31.83 | - | 14 | Oct 6, 2026 | |
| RVTY Revvity | Initiated Coverage: Buy | n/a | $157.00 | - | 1 | Oct 5, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | n/a | $7.36 | - | 10 | Sep 30, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | n/a | $70.11 | - | 11 | Sep 29, 2026 | |
| AVTR Avantor | Reiterated: Hold | n/a | $16.05 | - | 10 | Sep 21, 2026 | |
| VCYT Veracyte | Reiterated: Buy | n/a | $50.01 | - | 2 | Sep 15, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $178.80 | - | 5 | Sep 8, 2026 | |
| QGEN Qiagen | Rated: Hold | n/a | $50.22 | - | 3 | Aug 24, 2026 | |
| SERA Sera Prognostics | Reiterated: Buy | n/a | $2.04 | - | 2 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1633 | - | 1 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $72.66 | - | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.25 | - | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.81 | - | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $414.30 | - | 1 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.26 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $113.32 | - | 1 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.38 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $462.72 | - | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $87.41 | - | 2 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $152.78 | - | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $137.20 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $72.22 | - | 2 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.64 | - | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $176.94 | - | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $697.00 | - | 11 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $412.62 | - | 12 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $232.23 | - | 9 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.59 | - | 10 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $11.21 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $359.41 | n/a | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $85.83 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.26 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.19 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | - | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $187.50 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $361.39 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $135.90 | n/a | 1 | Nov 21, 2017 |
NeoGenomics
Oct 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.38
Upside: -
Option Care Health
Oct 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $31.83
Upside: -
Revvity
Oct 5, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $157.00
Upside: -
Alpha Teknova
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.36
Upside: -
10x Genomics
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $70.11
Upside: -
Avantor
Sep 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.05
Upside: -
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $50.01
Upside: -
Guardant Health
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $178.80
Upside: -
Qiagen
Aug 24, 2026
Rated: Hold
Price Target: n/a
Current: $50.22
Upside: -
Sera Prognostics
Aug 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.04
Upside: -
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.1633
Upside: -
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $72.66
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.25
Upside: -
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.81
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $414.30
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.26
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $113.32
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.38
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $462.72
Upside: -
Aug 3, 2026
Rated: Hold
Price Target: n/a
Current: $87.41
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $152.78
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $137.20
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $72.22
Upside: -
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.64
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $176.94
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $697.00
Upside: -
Jul 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $412.62
Upside: -
Jul 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $232.23
Upside: -
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $1.59
Upside: -
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $11.21
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $359.41
Upside: n/a
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $85.83
Upside: n/a
Aug 22, 2022
Reiterated: Buy
Price Target: n/a
Current: $15.26
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $9.19
Upside: n/a
Aug 4, 2021
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $187.50
Upside: n/a
Dec 3, 2018
Reiterated: Buy
Price Target: n/a
Current: $361.39
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $135.90
Upside: n/a